Advertisement

Topics

Latest Dermatology NewsRSS

10:29 EDT 20th September 2017 | BioPortfolio

Sun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of Response of 26 Months in Treatment of Locally Advanced Basal Cell Carcinoma

Incorporates 30-month data showing sustained, durable efficacy and safety of 200-mg dose Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries or associate companies) today announced that one of its wholly owned subsidiaries has received approval fr...

NovaBay Pharmaceuticals Receives Notification of Noncompliance with Additional NYSE American Continued Listing Standards

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces receipt of a letter from NYSE American LLC (“NYSE American” or the “Exchange”) on September 14, 2017 stating that it is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (“Company Guide”) requiring stockholders...

West Dermatology & Skin Cancer Center to Have Grand Opening in San Diego, CA

Mark your calendars for September 21, 2017, the grand opening of this brand new innovative skin cancer treatment and research center. San Diego, CA (PRWEB) September 20, 2017 West Dermatology, the foremost network of dermatology and skin cancer centers in the southwest United States, is proud to announce the grand opening of the West Dermatology & Skin Cancer Center in San Diego, CA. This new...

DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development

CUPERTINO, Calif., Sept. 20, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development.  Dr. Theeuwes joins DURECT from Johnson & Johnson where she spent 18 years, most recently as Compound Development Team Leader for Janssen Pharmaceutical's global public health initiatives where she le...

Sensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare Conference

BOCA RATON, Fla., Sept. 20, 2017 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will present at the Ladenburg Thalmann Healthcare Conference on Tuesday, September 26, 2017 at 4:00 p.m. Eastern time....

Cancer Horizons Forms an Alliance With Lexli International Inc. to Make Skin-Care Products Available Free to Cancer Patients, Launches Compassionate Cancer Patient Resources™ Program

SALT LAKE CITY, Sept. 20, 2017 /PRNewswire/ -- Cancer Horizons, the premier online portal exclusively for cancer patients, announced today that it has formed an alliance with Lexli International, Inc., noted developer of a leading line of aloe-based skin care products, to provide exclusively to those battling cancer a generous 4-oz. bottle of Lexli's aloe-based Hand & Body Lotion FREE of ...

Edesa Biotech Completes Financing to Develop Novel Dermatology and Anorectal Treatments

MARKHAM, ON, Sept. 20, 2017 /PRNewswire/ - Edesa Biotech Inc., a clinical-stage private company announced today the completion of a $7 million Series A financing.  The internationally syndicated investment was led by Lumira Capital and included participation from Pharmascience Inc., Inveready Technology Investment Group and a number of Canadian family offices.  The funds from this financ...

Caring for your own wounds: Lessons from the burn unit

“Someone call for a body bag.” These were words that I didn’t expect to hear on my final day of burn surgery at large metropolitan hospital. We had just planned on a routine burn excision and skin grafting. Our patient, Faith, was a seven-year-old girl with third-degree burns to 85 percent of her body from […]

Global Low Trauma/Skin Friendly Adhesives Market Research Report 20112023 [Report Updated: 30082017] Prices from USD $2280

SummaryLow trauma adhesives are skinfriendly adhesives for bandages, dressings and surgical tapes. The goal is not only to alleviate pain when removing skin adhesives, but also to avoid exacerbating existing wounds and ulcers or creating new ones."The global Low Trauma/Skin Friendly Adhesives market will reach Volume Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define,...

Corbus Pharmaceuticals Announces Presentation of Six Abstracts and New Anabasum Data at 2017 ACR Annual Meeting

NORWOOD, MA--(Marketwired - September 20, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology ("ACR") 2017 Annual Meeting being held Novem...

Fire ant venom to combat thick skin

Researchers say compounds from fire ant venom could be used to develop psoriasis treatments which limit skin-thickening side effects.

The Benefits of Calendula Officianalis for Protection Against the Harmful Side Effects of Radiation

BOSTON, Sept. 19, 2017 /PRNewswire/ -- Based on the Oncology Nursing Society's evidence-based study; Putting Evidence Into Practice: Evidence-based Interventions in Radiation Dermatitis there is increased demand from radiation oncologists and nurses seeking help for skin side effects that can delay radiation therapy treatments.  Unfortunately, no gold standard exists for the prevention o...

AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth

IRVINE, Calif., Sept. 19, 2017 /PRNewswire/ -- AIVITA Biomedical today announced the discovery of a new method for capturing and using intercellular signaling molecules to induce the reactivation of stem cell niches. The implication of this discovery is the ability to preserve or restore the microenvironment in which stem cells can self-renew and promote the healthy growth and maintenance of human...

Newly Launched All Calm™ Clinical Redness Corrector SPF 50 from Colorescience® Wins Fall Beauty O-Ward

CARLSBAD, Calif., Sept. 19, 2017 /PRNewswire/ -- Colorescience®, the leading dermatologist-recommended skin health cosmetics company, has earned a Fall Beauty O-Ward for their new All Calm™ Clinical Redness Corrector SPF 50, launched in August 2017. A first-and-only product created to instantly neutralize redness and soothe sensitive skin, it was created to offer immediate color correction...

Allergan Innovation Recognized With Three 2017 Allure Best of Beauty Breakthrough Awards

DUBLIN, Sept. 19, 2017 /PRNewswire/ -- For over 17 years, the highly-coveted Allure Best of Beauty Breakthrough Awards have recognized hair, makeup and skin products, fragrances and devices  for their innovative formulations, performance and technologies.  Today Allergan plc (NYSE: AGN) is happy to announce that Allure has awarded the 2017 Best of Beauty Breakthrough Award to three ...

How UV Radiation Causes DNA Mutations

We all know that we are supposed to put on sunscreen in the summer months to protect ourselves from skin cancer, and the connection between sun exposure and cancer is well documented (Koh et al., 1996; Armstrong and Cust, 2017). UV-A and UV-B rays from the sun interact with the DNA in our skin and… The post How UV Radiation Causes DNA Mutations appeared first on Bitesize Bio.

Leading Dermatologists Pave The Future During 2017 WDS Media Day

MILWAUKEE, Sept. 19, 2017 /PRNewswire/ -- The Women's Dermatologic Society (WDS) presents its bi-annual Media Day on October 12, 2017 at the Gansevoort Meatpacking in New York City. The luncheon brings together the brightest minds in dermatology to explore the advances, techniques and technologies that are rapidly revolutionizing the way we care for our skin and embrace aging with confidence. &nbs...

Biologics in Dermatology: Considerations for Patients and Clinical Trials, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - September 19, 2017) - In an upcoming presentation experts Darcee Duke Strube, Senior Vice President of Novella Clinical's Dermatology Division and Dr. James J Milbauer, Dermatologist, Medical Monitor and Advisor will discuss the evolution of biologics within the dermatology landscape, with an emphasis on clinical trial considerations for sponsors developing biologic ag...

Avadim Technologies Inc. Announces Partnership With Cardinal Health, Inc.

ASHEVILLE, NC--(Marketwired - September 19, 2017) - Avadim Technologies Inc. ("Avadim"), the Bionome Therapies™ life sciences company, today announced that is has partnered with Cardinal Health (NYSE: CAH), a global leader in healthcare services and products, to provide Avadim's line of topical bionome therapies, Theraworx®, to Cardinal Health's customers. Together, Avadim and Cardinal Health'...

Leading Physician Organizations Call for Shingles Vaccine for People Over 50

SAN FRANCISCO, Sept. 18, 2017 /PRNewswire-USNewswire/ -- The American Academy of Ophthalmology and the American Dermatological Association recommend people age 50 and older get the shingles vaccine – 10 years younger than a previous recommendation. It is now estimated that one in three people will develop shingles (herpes zoster), with the greatest number of cases of occuring in people...

Advocates Tez Anderson and Josh Robbins to Host Facebook Live Conversation on HIV/AIDS and Aging Awareness Day to Discuss Issues Affecting Long Term Survivors

(NASDAQ: JAGX) – Today marks National HIV/AIDS and Aging Awareness Day (NHAAD), observed annually to focus on the challenges facing the aging population with regards to HIV prevention, testing, care and treatment. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170918005864/en/

Recros Medica Appoints Thomas A. Albright as President and CEO

SAN DIEGO, Sept. 18, 2017 /PRNewswire/ -- Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced today that Thomas A. Albright has been named President and CEO, and will also serve on the Company's Board of Directors. Mr. Albright brings nearly 35 years of healthcare experience to Recros Medica, with medical aesthet...

Serlopitant Pruritus Reduction Results from Two Phase 2 Studies Presented at the 26th European Academy of Dermatology and Venereology

MENLO PARK, Calif., Sept. 18, 2017 /PRNewswire/ -- Menlo Therapeutics Inc. announced today the presentation of data from two phase 2 clinical studies of serlopitant at the 2017 EADV conference, the leading annual dermatology meeting in Europe.  A 257-patient phase 2 trial (TCP-101) evaluating serlopitant for the treatment of chronic pruritus (itch) successfully met its primary efficacy e...

SkinCeuticals Announces The Launch Of New Cosmeceutical Cleansers

NEW YORK, Sept. 18, 2017 /PRNewswire/ -- SkinCeuticals, a leader in advanced skincare technology, announces the launch of their new cleansing range consisting of newly optimized formulas, new packaging and two new cleansers: Replenishing Cleanser and Smoothing Cleanser. Created to meet the exacting standards of skincare professionals, SkinCeuticals cosmeceutical cleansers are formulated and t...

Principia Biopharma Presents Late-Breaking Interim Phase 2 Data of PRN1008 in Pemphigus at European Academy of Dermatology and Venereology Meeting

– In interim analysis, trial met primary endpoint of control of disease activity within four weeks after PRN1008 treatment – Principia Biopharma, a private, clinical-stage biopharmaceutical company, today announced a late-breaking oral presentation of interim data from a Phase 2 trial of PRN1008, a reversible covalent Bruton’s Tyrosine Kinase (BT...

Quick Search
Advertisement
 

review and buy Dermatology market research data and corporate reports here